Loading data for LMAT — first visit, this takes a few seconds.
LeMaitre Vascular, Inc. (LMAT)
NasdaqGM: LMAT
· 即時價格 · USD
80.67
+0.18 (0.22%)
收盤價： Sep 04, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
LeMaitre Vascular, Inc.（LMAT）股價、分析與資料
無可用資料
| 買價 | 88.97 |
| 市值 | 1.84B |
| 營收 (ttm) | 262M |
| 淨利（ttm） | 65.7M |
| 0.49 | |
| 2.86 | |
| 28.21 | |
| 25.38 | |
| P/B (ttm) | 4.39 |
| P/S (ttm) | 7.03 |
| 財報日期 | Nov 5, 2026 |
| 賣價 | 109.9 |
| 成交量 | 167,361 |
| 20 日平均成交量 | 370,319 |
| 開盤價 | 79.22 |
| 前收盤價 | 80.49 |
| 當日區間 | 79.04 - 81.00 |
| 52 週範圍 | 78.27 - 118.01 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | $1.00 (1.24%) |
| 除息日 | Aug 20, 2026 |
關於 LMAT
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi i...
完整的公司簡介財報驚奇
LeMaitre Vascular 已於 Aug 4, 2026 公布季度財報：
- 營收為 $70.38M 低於預期 $0, 年增 9.57% 成長.
- 每股盈餘為 0.74 低於預期 -0.07, 年增 23.33% 成長.
第 1 頁，共 2 頁